Compounds > 4-n-butylresorcinol
Page last updated: 2024-09-05

4-n-butylresorcinol and B16 Melanoma

4-n-butylresorcinol has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeong, EM; Kim, HJ; Kim, IG; Lee, JH; Lee, KB; Lee, SJ; Park, SC; Son, YH1

Other Studies

1 other study(ies) available for 4-n-butylresorcinol and B16 Melanoma

ArticleYear
4-n-butylresorcinol enhances proteolytic degradation of tyrosinase in B16F10 melanoma cells.
    International journal of cosmetic science, 2017, Volume: 39, Issue:3

    Topics: Animals; Cell Line, Tumor; Glycosylation; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Proteolysis; Resorcinols

2017